Changes within T cell receptor v(β) subsets in infants following measles vaccination

Clinical Immunology and Immunopathology

Volumn 79, Issue 2, 1996, Pages 163-170

  Auwaerter, Paul G ^a   Hussey, Gregory D ^b   Goddard, Elizabeth A ^b   Hughes, Jane ^b   Ryon, Judith J ^a,e   Strebel, Peter M ^c   Beatty, David ^b   Griffin, Diane E ^a,d,f  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^f JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR BETA CHAIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNE DEFICIENCY; INFANT; MEASLES VACCINATION; MORTALITY; NORMAL HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029924545     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0063     Document Type: Article

References (51)

1. Henderson, R. H., Keja, J., Hayden, G., et al., Immunizing the children of the world: Progress and prospects. Bull. W. H. O. 66, 35-543, 1988
2. Aaby, P., Bukh, J., Kronborg, D., Lisse, I. M., and daSilva, M. C., Delayed excess mortality after exposuretomeasles during the first six months of line. Am. J. Epidemiol. 132, 211-219, 1990.
3. Garenne, M., and Aaby, P., Pattern of exposure and measles mortality in Senegal. J. Infect. Dis. 161, 1088-1094, 1990.
4. Miller, D. L., Frequency of complications of measles. Br. Med. J. 2, 75-78, 1964.
5. Beckford, A. P., Kaschula, R. O. C., and Stephen, C., Factors associated with fatal cases of measles: A retrospective autopsy study. S. Afr. Med. J. 68, 858-863, 1985
6. von Pirquet, C., Verhalten der Kutanen tuberkulin-reaktion wahrend der Masern. Deutsch. Med. Wochensch 34, 1297-1300. 1908
7. Ward, B. J., Johnson, R. T., Vaisberg, A., Jauregui, A., and Griffin, D. E., Cytokine production in vitro and the lymphoprolifer ative defect of natural measles infection. Clin. Immunol. Immunopathol. 55, 315-326, 1990
8. Ward, B. J. and Griffin, D. E. Differential CD4T-cell activation in measles. J. Infect. Dis. 168, 275-281, 1993
9. Casali, P., Miroru, N., and McChesney, M., Immunosuppression by measles virus. In "Viral Induced Immune Supperession" (S. Spector, Ed.), Chap. 18, Plenum Press, New York, NY, 1987.
10. Mellman, W. J., and Wettan, R., Depression of the tuberculin reaction by attenuated measles virus vaccine. J. Lab Clin. Med. 61, 453-458, 1963
11. Smedman, L., Joki, A., da Silva, A. P. J., Troye-Blomber, M., Aronsson, B., and Perlmann, P., Immune suppression after measles vaccination. Acta Pædiatr. 83, 164-168, 1994.
12. Garrene, M., Leroy, O., Beau, J., and Sene, I., Child mortality after high-titer measles vaccines: Prospective study in Senegal. Lancet 338, 903-907, 1991.
13. Tidjani, O., Grunisky, B., Guerin, N., Levy-Bruhl, D., Leram, N., Xuereff, C., and Tatagon, K., Serological effects of Edmonston-Zagreb, Schwarz, Al K-C measles vaccine strains given at ages 4-5 months and 8-10 months. Lancet 2, 1357-1360, 1989.
14. World Health Organization Expanded Programme of Immunization. Safety and efficacy of high titer vaccine at six months of age. Wkly. Epidemiol. Rec. 66, 249-251, 1991.
15. Expanded Programme on Immunization; Global Advisory Group. Wkly. Epidemiol. Rec. 67, 357-361, 1992.
16. Holt, E. A., Moulton, L. H., Siberry, G. K., and Halsey, N. A., Differential mortality by measles vaccine titer and sex. J. Infect. Dis. 168, 1087-1096, 1993.
17. Aaby, P., Knudsen, K., Whittle, H., Lisse, I. M., Tharrup, J., Paulsen, A., Sodemann, M., Jakobsen, M., Brink, L., Gansted, U., et al., Long term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: Increased female mortality. J. Pedi atr. 122, 904-908, 1993.
18. León, M. E, Ward, B., Kaneshino, R., Hernandez, H., Berry, S., Vaisberg, A., Escamilla, J., Campos, M., Belloma, S., Azabade, V., et al., Immunologic parameters two years after high-titer measles immunization in Peruvian children. J. Infect. Dis. 168, 1097-1104, 1993.
19. β repertoire in HIV-1 infection and disease. Semin. Immunol. 5, 175-185, 1993.
20. β prepertoires. Infect. Immun. 63, 1235-1240, 1995.
21. Hussey, G. D., Goddard, E. A., Hughes, J., Ryon, J. J., Kerran, M., Carelse, E., Strebel, P. M., Markowitz, L. E., Moodie, J., Barron, P., Latief, Z., Sayed, R., Beatty, D., and Griffin, D. E., The effect of Edmonston-Zagreb and Schwarz measles vaccines on immune responses in infants. J. Infect. Dis., in press.
22. Albrecht, P., Hermann, K., and Burns, G. R., Role of virus strain in conventional and enhanced measles plaque neutralization test. J. Virol. Method 3, 251-260, 1981.
23. Panzara, M. A., Gussoni, E., Steinman, L., and Oksenberg, J. R., Analysis of the T cell repertoire using the PCR and specific oligonucleotide primers. BioTech 5, 728-735, 1992.
24. β usage to immunodominant regions of myelin basic protein. Science 248, 1016-1019, 1990.
25. β gene usage in human peripheral blood lymphocytes. J. Immunol. 149, 1802-1808, 1992.
26. Ura, Y., Hara, T., Nagata, M., Mizuno, Y., Ueda, K., Matsuo, M., Mori, Y., and Miyazaki, S., T cell activation and T cell receptor variable region gene usage in measles. Acta Pediatr. Jpn. 34, 273-277, 1992.
27. Gold, D. P., TCR V gene usage in autoimmunity. Curr. Opin. Immunol. 6, 907-912, 1994.
28. Wang, X. H., Ohmen, J. D., Uyemura, K., Rea, T. H., Kronenbeg, M., and Modlin, A. L., Selection of T lymphocytes bearing limited T cell receptor β chains in the response to a human pathogen. Proc. Natl. Acad. Sci. USA 90, 188-192, 1993.
29. Griffin, D. E., Ward, B. J., Jauregui, E., Johnson, R. T., and Vaisberg, A., Immune activation during measles: Interferon-γ and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. J. Infect. Dis. 161, 449-451, 1990.
30. McFarlin, D. E., and McFarland, H. F., Multiple sclerosis. N. Engl. J. Med. 307, 1183-1185, 1982.
31. Ekbom, A., Wakefield, A. J., Zack, M., and Adami, H. O., Perinatal measles infection and subsequent Crohn's disease. Lancet 334, 508-510, 1994.
32. a-encoded antigens Nature 332, 40-45, 1988.
33. Pullen, A. M., Marrack, P., and Kappler, J., The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens. Nature 335, 796-801, 1988.
34. β-specific super antigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56, 27-35, 1989.
35. Webb, S., Morris, C., and Sprent, J., Extrathymic tolerance of mature T-cells: Clonal elimination as a consequence of immunity. Cell 63, 1249-1256, 1990.
36. + T-cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349, 245-248, 1991.
37. Huang, L., and Crispe, I. N., Superantigen-driven peripheral deletion of T-cells. J. Immunol. 151, 1844-1851, 1993.
38. McCormack, J, Callahan, J. E., Kappler, J., and Marrack, P., Profound depletion of mature T-cells in vivo by chronic exposure to superantigen. J. Immunol. 150, 3785-3792, 1993.
39. Herman, A., Kappler, J. W., Marrack, P., and Pullen, A. M., Superantigens: Mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9, 745-772, 1991.
40. Kotzin, B. L., Leung, D. Y. M, Kappler, J., and Marrack, P., nol. 54, 99-166, 1993.
41. Lagrange, P. H., Mackaness, G. B., and Miller, T. E., Influence of dose and route of antigen injection on the immunological induction of T cells. J. Exp. Med. 139, 528-542, 1974.
42. Moskophidis, D., Lechner, F., Pincher, H., and Zinkernagel, R. M., Virus persistence in acutely infected immunocompetant mice by exhaustion of anti-viral cytotoxiceffector T-cells. Nature 362, 758-761, 1993.
43. van Binnendijk, R. S., van der Heijden, R. W. J., van Amerongen, G., Uytde Haag, F. G. C. M., and Osterhaus, A. D. M. E., Virus replication and development of specific immunity in macaques after infection with different measles virus strains. J. Infect. Dis. 170, 443-448, 1994.
44. Sullivan, J. L., Barry, D. W., Lucas, S. J., and Albrecht, P., Measles infection of human mononuclear cells. I. Acuteinfection of peripheral blood lymphocytes and monocytes. J. Exp. Med. 142, 773-784, 1975.
45. Joseph, B. S., Lampert, P. W., and Oldstone, M. B. A., Replication and persistence of measles virus in defined subpopulations of human leukocytes. J. Virol. 16, 1638-1649, 1975.
46. Lucas, C. J., Libels-Postman, J. C., Rezee, A., and Galma, J.M.D., Activation of measles virus from silently infected human lymphocytes. J. Exp. Med. 148, 940-952, 1978.
47. Acha-Orbea, H., Roles of superantigens in microbial infections? Res. Immunol. 144, 198-201, 1993.
48. Auwaerter, P. G., Kaneshima, H., McCune, J. M., Wiegand, G., and Griffin, D. E., Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. J. Virol. in press.
49. Chino, F., Kodama, H., Ohkawa, T., and Egashira, Y., Alterations of the thymus and peripheral lymphoid tissues in fatal measles. Acta Pathol. Jpn. 29, 493-507, 1979.
50. Kobune, F., Sakata, H., and Suigiura, A., Marmoset lymphoblastoid cells are a sensitive host for isolation of measles virus. J. Virol. 64, 700-705, 1990.
51. Kendall, M. D., Functional anatomy of the thymic microenvironment. J. Anat. 177, 1-29, 1991.